Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Viatris Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
VTRS
Nasdaq
2834
https://www.viatris.com/en
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Viatris Inc
Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline
- Mar 27th, 2024 10:59 am
Is Viatris a Great Dividend Stock or Just a Value Trap?
- Mar 14th, 2024 1:53 pm
2 Dirt Cheap Dividend Stocks to Buy and Hold
- Mar 11th, 2024 1:45 pm
UPDATE 2-US FDA declines to approve Viatris's injection for multiple sclerosis
- Mar 11th, 2024 11:24 am
Viatris Inc's Dividend Analysis
- Mar 8th, 2024 10:04 am
Insider Sell: President of Greater China Xiangyang Ni Sells 21,532 Shares of Viatris Inc (VTRS)
- Mar 6th, 2024 4:52 am
Viatris Inc. (NASDAQ:VTRS) Q4 2023 Earnings Call Transcript
- Mar 5th, 2024 3:38 pm
13 Best Pharma Dividend Stocks To Buy in 2024
- Mar 5th, 2024 7:56 am
Viatris' (VTRS) Generic Declines in Q4, Yupleri Sales Rise
- Mar 4th, 2024 4:24 pm
Q4 2023 Viatris Inc Earnings Call
- Feb 29th, 2024 3:43 am
Viatris' (VTRS) Q4 Earnings and Revenues Miss Estimates
- Feb 28th, 2024 2:50 pm
Viatris (VTRS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
- Feb 28th, 2024 2:30 pm
Viatris forecasts strong 2024 sales on higher demand for branded drugs
- Feb 28th, 2024 1:19 pm
Viatris Inc (VTRS) Meets 2023 Financial Targets and Sets Course for Continued Growth in 2024
- Feb 28th, 2024 12:52 pm
Viatris pays $350M to gain two drugs from Idorsia
- Feb 28th, 2024 11:34 am
Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
- Feb 28th, 2024 11:30 am
Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration
- Feb 28th, 2024 6:00 am
3 Overextended Stocks That Need to Slash Their Dividends ASAP
- Feb 27th, 2024 8:19 pm
Theravance's (TBPH) Q4 Earnings & Revenues Surpass Estimates
- Feb 27th, 2024 4:47 pm
Viatris (VTRS) to Report Q4 Earnings: Is a Beat in Store?
- Feb 23rd, 2024 4:54 pm
Scroll